Jellinger K A
L. Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, Vienna, Austria.
J Neural Transm Suppl. 1995;46:33-57.
Although neuropathological examination is the "gold standard" for the diagnosis of neurodegenerative disorders with extrapyramidal features, difficulties may arise in the morphological differentiation of some of these disorders. They are all associated with major structural pathology within or directly affecting the basal ganglia and related neuronal loops. In addition to progressive neuronal loss and gliosis involving specific subcortico-cortical systems or multiple circuits, many of these disorders are characterized by intracellular neuronal and/or glial inclusions indicating cytoskeletal dysmetabolism that may serve as important diagnostic signposts, whereas in other disorders, e.g. Huntington's disease, pallidal or other multisystem degenerations, no such cytopathological hallmarks have been described. The neuropathological diagnostic criteria for the major neurodegenerative disorders with extrapyramidal features based on structural cytoskeletal features and morphological lesion patterns are reviewed, and the difficulties in nosological differentiation between some groups of disorders are discussed. Although current post mortem diagnostic criteria with additional clinical information are useful in the differentiation of these disorders, in view of many clinicopathological overlaps and the lack of in vivo markers, further standardization of criteria is warranted for their exact classification order to provide further insight into their pathophysiology and pathogenesis as a basis for future therapeutic strategies.
尽管神经病理学检查是诊断具有锥体外系特征的神经退行性疾病的“金标准”,但在对其中一些疾病进行形态学鉴别时可能会遇到困难。它们都与基底神经节内或直接影响基底神经节及相关神经元环路的主要结构病理学相关。除了涉及特定皮质下 - 皮质系统或多个回路的进行性神经元丢失和胶质细胞增生外,这些疾病中的许多还具有细胞内神经元和/或胶质细胞内含物,表明细胞骨架代谢异常,这可能是重要的诊断标志,而在其他疾病中,如亨廷顿病、苍白球或其他多系统变性疾病,则未描述此类细胞病理学特征。本文回顾了基于结构细胞骨架特征和形态学病变模式的主要具有锥体外系特征的神经退行性疾病的神经病理学诊断标准,并讨论了某些疾病组在分类学鉴别上的困难。尽管目前结合额外临床信息的尸检诊断标准有助于区分这些疾病,但鉴于许多临床病理重叠以及缺乏活体标记物,为了对其进行准确分类以便进一步深入了解其病理生理学和发病机制作为未来治疗策略的基础,有必要进一步规范标准。